Market Research Report
Heparin Market Size By Product, By Source, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026
|Published by||Global Market Insights Inc.||Product code||963774|
|Published||Content info||150 Pages
Delivery time: 2-3 business days
|Heparin Market Size By Product, By Source, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026|
|Published: October 12, 2020||Content info: 150 Pages||
Heparin Market Size By Product (Low Molecular Weight Heparin, Unfractionated Heparin), By Source (Porcine, Bovine), By Application (Venous Thromboembolism, Atrial Fibrillation/Flutter, Coronary Artery Disease), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026.
Heparin market is likely to witness exponential growth over the forecast time period owing to high product application for treatment of atrial fibrillation/flutter, venous thromboembolism, and coronary artery disease. Heparin is an known as an injectable anticoagulant that is used for preventing the formation of blood clots in the vessels. It is majorly used to prevent the formation of blood clots among people which is caused by certain medical procedures or medical conditions. In fact, heparin is also utilized before surgery to decrease the risk of blood clots.
Heparin essentially comes in two forms, one solution which is injected intravenously and the other which is an injectable solution, which is mainly injected under an individual's skin.
Heparin market is divided into different segments in terms of product, source, application, distribution channel, and regional landscape.
Based on product, the heparin market is classified into unfractionated heparin and low molecular weight heparin. Among these, unfractionated heparin segment accounted for market share of over 14.8% and is projected to witness remunerative gains over the coming years. The product is known to be a fast-acting blood thinner, working together with antithrombin, which is a natural protein in the body for blocking the formation of clots.
In comparison to other heparin formulations, unfractionated heparin is generally inexpensive. Also, it does not break down the clots, in fact, it keeps them from growing and stops novel ones from forming.
With respect to source, the heparin market is categorized into bovine and porcine. Among these, bovine segment accounted for nearly $50.4 million in 2019 and is projected to witness substantial growth through the forecast timeframe.
In terms of application, the overall heparin market is bifurcated into coronary artery disease, atrial fibrillation/flutter, venous thromboembolism, and others. Among these, atrial fibrillation/flutter segment will witness substantial growth over the coming years. In 2019, the segment represented a valuation of approximately $730.4 million. In patients with AF (atrial fibrillation) that might have persisted for nearly 48 hours or above, heparin could be utilized to decrease the thrombus formation and embolization risk until the warfarin level is cardioversion or therapeutic is performed.
With respect to distribution channel, the heparin market is segmented into online pharmacy, retail pharmacy, and hospital pharmacy. Among these, hospital pharmacy segment accounted for a revenue share of approximately $2.2 billion in 2019 and is likely to exhibit robust growth over the coming years.
From a regional frame of reference, Latin America heparin market will reach a valuation of approximately $327.3 million by the end of the analysis timeline. Middle East & Africa region will witness substantial growth over the coming years. In 2019, the regional market generated revenue of $91.6 million with market estimates expecting the industry to register a rising growth trend.